Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake EP News Bureau Jul 31, 2020 Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics
Strides Board approves incremental investments in Stelis EP News Bureau Sep 20, 2019 It will accelerate Strides’ re-entry into sterile injectables business post the completion of the Company’s non-compete period in…
Cipla inks investment pact with FIL Capital Investment EP News Bureau Nov 30, 2015 No financial deals of the agreement were disclosed
